Aortitis which developed after the administration of granulocyte-colony stimulating factor

Tomoyuki Mukai1,2, Shinichiro Kubo3, Yoshitaka Morita1

  • 1Department of Rheumatology, Kawasaki Medical School, Kurashiki, Japan.

Insights

Granulocyte-colony stimulating factor (G-CSF) can cause drug-induced aortitis, a rare condition. Early recognition and corticosteroid treatment are crucial for managing this side effect in cancer patients.

Area of Science:

  • Cardiovascular Medicine
  • Oncology
  • Pharmacology

Background:

  • Drug-induced aortitis is an uncommon but serious condition.
  • Prompt diagnosis and treatment are essential to prevent irreversible aortic damage.
  • Granulocyte-colony stimulating factor (G-CSF) is used in chemotherapy to boost white blood cell counts.

Observation:

  • A 66-year-old woman developed aortitis following G-CSF administration during breast cancer chemotherapy.
  • Computed tomography (CT) and magnetic resonance imaging revealed significant aortic wall thickening.
  • Other potential causes of aortitis were ruled out.

Findings:

  • A strong association was suspected between G-CSF use and the development of aortitis.
  • Corticosteroid therapy led to rapid regression of the aortitis, confirmed by follow-up CT scans.
  • Limited case reports suggest a causative role for G-CSF in aortitis development.

Implications:

  • G-CSF-associated aortitis is an under-recognized condition, potentially leading to delayed diagnosis and treatment.
  • Oncologists and rheumatologists must be aware of this potential adverse effect of G-CSF.
  • Increased awareness can facilitate timely intervention, preventing severe aortic complications.

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.7K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.7K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
256
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
143
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
831